PL376362A1 - Sól cetylopirydynowa środka przeciwzapalnego i zawierające ją kompozycje farmaceutyczne - Google Patents
Sól cetylopirydynowa środka przeciwzapalnego i zawierające ją kompozycje farmaceutyczneInfo
- Publication number
- PL376362A1 PL376362A1 PL04376362A PL37636204A PL376362A1 PL 376362 A1 PL376362 A1 PL 376362A1 PL 04376362 A PL04376362 A PL 04376362A PL 37636204 A PL37636204 A PL 37636204A PL 376362 A1 PL376362 A1 PL 376362A1
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- inflammatory agent
- cetylpyridinium salt
- cetylpyridinium
- Prior art date
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical class CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/18—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/20—Quaternary compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000269A ITMI20030269A1 (it) | 2003-02-14 | 2003-02-14 | Sale di cetilpiridino di un agente antiinfiammatorio |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL376362A1 true PL376362A1 (pl) | 2005-12-27 |
Family
ID=32866065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04376362A PL376362A1 (pl) | 2003-02-14 | 2004-02-12 | Sól cetylopirydynowa środka przeciwzapalnego i zawierające ją kompozycje farmaceutyczne |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7250428B2 (pl) |
| EP (1) | EP1592657A1 (pl) |
| JP (1) | JP2006517565A (pl) |
| KR (1) | KR20050101186A (pl) |
| CN (1) | CN1318389C (pl) |
| AR (1) | AR043171A1 (pl) |
| AU (1) | AU2004212154A1 (pl) |
| CA (1) | CA2511900A1 (pl) |
| EA (1) | EA008003B1 (pl) |
| GE (1) | GEP20064009B (pl) |
| HK (1) | HK1080449A1 (pl) |
| IL (1) | IL169312A (pl) |
| IT (1) | ITMI20030269A1 (pl) |
| MX (1) | MXPA05008589A (pl) |
| PL (1) | PL376362A1 (pl) |
| WO (1) | WO2004072017A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY129765A (en) * | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
| WO2011009010A1 (en) * | 2009-07-15 | 2011-01-20 | University Of Medicine And Dentistry Of New Jersey | Novel compounds for inhibiting eef2 kinase activity |
| KR101666659B1 (ko) | 2014-06-12 | 2016-10-14 | 한국생명공학연구원 | 부틸 피리디늄 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물 |
| JP7214331B2 (ja) * | 2016-12-28 | 2023-01-30 | 小林製薬株式会社 | 医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT370721B (de) * | 1981-02-24 | 1983-04-25 | Ciba Geigy Ag | Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der |
| IT1228242B (it) * | 1986-11-13 | 1991-06-05 | Ricerfarma Srl Milano | Sale del diclofenac con idrossietilpirrolidina e composizioni farmaceutiche che lo contengono |
| IT1250636B (it) * | 1991-07-04 | 1995-04-21 | Ricerche Di Schiena Del Dr Mic | Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono. |
| US5614223A (en) * | 1992-05-04 | 1997-03-25 | Digestive Care Inc. | Intraoral medicament-releasing device |
| JP4013996B2 (ja) * | 1994-06-06 | 2007-11-28 | テムド トラスト | 腫瘍および感染部位に指向させるためのビオチン化合物 |
| DE19856101A1 (de) * | 1998-12-04 | 2000-06-08 | Labtec Gmbh | Mundhöhlen-Matrixpflaster |
| JP2000256186A (ja) * | 1999-03-05 | 2000-09-19 | Taisho Pharmaceut Co Ltd | 咽頭疾患用組成物 |
-
2003
- 2003-02-14 IT IT000269A patent/ITMI20030269A1/it unknown
-
2004
- 2004-02-12 US US10/544,224 patent/US7250428B2/en not_active Expired - Fee Related
- 2004-02-12 KR KR1020057013935A patent/KR20050101186A/ko not_active Ceased
- 2004-02-12 PL PL04376362A patent/PL376362A1/pl not_active Application Discontinuation
- 2004-02-12 EP EP04710394A patent/EP1592657A1/en not_active Withdrawn
- 2004-02-12 CA CA002511900A patent/CA2511900A1/en not_active Abandoned
- 2004-02-12 WO PCT/EP2004/001412 patent/WO2004072017A1/en not_active Ceased
- 2004-02-12 GE GEAP20048977A patent/GEP20064009B/en unknown
- 2004-02-12 JP JP2006501845A patent/JP2006517565A/ja not_active Ceased
- 2004-02-12 HK HK06100260.7A patent/HK1080449A1/zh unknown
- 2004-02-12 MX MXPA05008589A patent/MXPA05008589A/es not_active Application Discontinuation
- 2004-02-12 AU AU2004212154A patent/AU2004212154A1/en not_active Abandoned
- 2004-02-12 EA EA200501088A patent/EA008003B1/ru not_active IP Right Cessation
- 2004-02-12 CN CNB200480003068XA patent/CN1318389C/zh not_active Expired - Fee Related
- 2004-02-13 AR ARP040100444A patent/AR043171A1/es not_active Application Discontinuation
-
2005
- 2005-06-21 IL IL169312A patent/IL169312A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05008589A (es) | 2005-11-04 |
| EP1592657A1 (en) | 2005-11-09 |
| AU2004212154A1 (en) | 2004-08-26 |
| CN1745061A (zh) | 2006-03-08 |
| JP2006517565A (ja) | 2006-07-27 |
| US7250428B2 (en) | 2007-07-31 |
| KR20050101186A (ko) | 2005-10-20 |
| US20060142353A1 (en) | 2006-06-29 |
| ITMI20030269A1 (it) | 2004-08-15 |
| CA2511900A1 (en) | 2004-08-26 |
| EA200501088A1 (ru) | 2005-12-29 |
| GEP20064009B (en) | 2006-12-25 |
| WO2004072017A1 (en) | 2004-08-26 |
| IL169312A0 (en) | 2007-07-04 |
| IL169312A (en) | 2010-05-17 |
| CN1318389C (zh) | 2007-05-30 |
| HK1080449A1 (zh) | 2006-04-28 |
| AR043171A1 (es) | 2005-07-20 |
| EA008003B1 (ru) | 2007-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL163931A (en) | Derivatives of Tetrazycline Compounds Converted by Amino Methyl and Pharmaceutical Preparation Containing Them | |
| IL173930A0 (en) | Pharmaceutical compositions containing forms of r-baclofen | |
| IL197889A (en) | Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same | |
| IL173602A0 (en) | Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same | |
| EP1610742A4 (en) | METHODS AND COMPOSITIONS FOR ADMINISTERING TRPV1 AGONISTS | |
| IL165591A0 (en) | Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents pharmaceutical compositions including the same and methods fortheir use | |
| SI1354873T1 (en) | Salt of perindopril and pharmaceutical compositions containing it | |
| IL166108A0 (en) | Novel compounds pharmaceutical compositions containing same and methods of use for same | |
| IL173726A (en) | Pharmaceutical compositions containing n-n-dihaloamino acids and their uses | |
| IL173639A0 (en) | Ppar-activating compound and pharmaceutical composition containing same | |
| HUP0401711A3 (en) | N-heterocyclic inhibitors of tnf-alpha and pharmaceutical compositions containing them | |
| IL173051A0 (en) | N-glucoside derivatives and pharmaceutical compositions containing the same | |
| IL164987A0 (en) | Proline derivatives and pharmaceutical compositions containing | |
| IL164185A0 (en) | Pharmaceutical compositions containing trifluoromethylphenyl amide derivatives | |
| IL171997A0 (en) | Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same | |
| IL175214A0 (en) | 2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same | |
| IL164022A0 (en) | Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same | |
| IL172159A0 (en) | 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same | |
| IL170313A (en) | Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them | |
| IL166621A0 (en) | Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same | |
| IL166054A0 (en) | Novel compounds pharmaceutical compositions containing same and methods of use for same | |
| IL163959A (en) | Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them | |
| ZA200508204B (en) | Pharmaceutical composition of atorvastatin | |
| SI1646378T1 (sl) | Farmacevtski sestavki, ki vsebujejo askorbinsko kislino, za zdravljenje gliviäśnih superinfekcij ingliviäśnih recidivov | |
| IL165902A0 (en) | Magnesium salt of panroprazole and its hydrates and pharmaceutical compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |